| Amiel Narcelle Redfish, PA | |
|
104 W Birch, Arlington, SD 57212-0291 | |
| (605) 983-3283 | |
| (605) 983-5112 |
| Full Name | Amiel Narcelle Redfish |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 104 W Birch, Arlington, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457418857 | NPI | - | NPPES |
| 5300830 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | SD0173 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amiel Narcelle Redfish, PA Po Box 291, 104 W. Birch, Arlington, SD 57212-0291 Ph: (605) 983-3283 | Amiel Narcelle Redfish, PA 104 W Birch, Arlington, SD 57212-0291 Ph: (605) 983-3283 |
News Archive
Children's own temperament could be driving the amount of TV they watch – according to new research from the University of East Anglia and Birkbeck, University of London.
Cord Blood America, Inc. today announced that it has entered into an agreement with Premera Blue Cross, a leading health plan provider with operations in Mountlake Terrace, Seattle and Spokane, Washington, and Anchorage, Alaska, and more than 1.4 million members, to store umbilical cord blood at a discounted rate consistent with other Blue Cross licensee contracts.
Pregnant women with higher blood levels of a common flame retardant had altered thyroid hormone levels, a result that could have implications for fetal health, according to a new study led by researchers at the University of California, Berkeley.
Knee injuries are among the top five reasons people visit an orthopedic surgeon for treatments, which include 719,000 total knee replacements performed annually in the United States. Now, new research reveals underlying biomechanics that may be involved in meniscus fibrocartilage function as well as dysfunction and could guide novel treatments for some of the most debilitating and costly orthopedic problems in the U.S., including meniscus tears and age-related joint degeneration.
Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.
› Verified 9 days ago